The use of reduced DOAC doses in atrial fibrillation patients does not always lead to good anticoagulation levels and avoid adverse events
| Title: | The use of reduced DOAC doses in atrial fibrillation patients does not always lead to good anticoagulation levels and avoid adverse events |
|---|---|
| Authors: | Palareti, Gualtiero a, ⁎; Testa, Sophie b; Legnani, Cristina a; Paoletti, Oriana b; Cini, Michela a; Antonucci, Emilia a; Pengo, Vittorio c; Poli, Daniela d; Ageno, Walter e; Prandoni, Paolo a; Prisco, Domenico f; Tosetto, Alberto g |
| Source: | In International Journal of Cardiology 1 December 2024 416 |
| Database: | ScienceDirect |